Cardiovasc Res 2004; 61: 461–70 PubMedCrossRef 13 Halliwell B, A

Cardiovasc Res 2004; 61: 461–70.PubMedCrossRef 13. Halliwell B, Aruoma OI. DNA damage by oxygen-derived species: its mechanism and measurement in mammalian systems. FEBS Lett 1991; 281: 9–19.PubMedCrossRef 14. Zhu YZ, Huang SH, Tan BKH, et al. Antioxidants in Chinese herbal medicines: a biochemical perspective. Nat

Prod Rep 2004; 21: 478–89.PubMedCrossRef 15. Zhong H, Xin H, Wu LX, et al. Salidroside attenuates apoptosis in ischemic cardiomyocytes: a mechanism through a mitochondria-dependent pathway. J Pharmacol Sci 2010; 114: 399–408.PubMedCrossRef 16. Schriner SE, find more Abrahamyan A, Avanessian A, et al. Decreased mitochondrial superoxide concentrations and enhanced protection against paraquat in Drosophila melanogaster supplemented with Rhodiola rosea. Free Radic Res 2009; 43: 836–43.PubMedCrossRef

17. Schriner SE, Avanesian A, Liu YX, et al. Protection of human cultured cells against oxidative stress by Rhodiola rosea selleck compound without activation of antioxidant defenses. Free Radic Biol Med 2009; 47: 577–84.PubMedCrossRef 18. Shen WS, Gao CH, Zhang H, et al. Effect of Rhodiola on serum troponin 1, cardiac integral backscatter and left ventricle ejection fraction of patients who received epirubicin-contained chemotherapy. Chin J Integr Trad West Med 2010; 12: 1250–2. 19. Hu X, Zhang X, Qiu S, et al. Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells. Biochem Biophys Res Commun 2010; 398: 62–7.PubMedCrossRef”
“Background Intracranial aneurysms are reported to occur in 1–10% of the population and are associated with considerable morbidity and mortality following rupture.[1–3] The Paclitaxel mouse estimated rate of aneurysm rupture ranges between 0–2% per year, and is dependent on factors such as family history and the size and location of the aneurysm; small aneurysms (<10 mm in diameter) in arteries in the front of the brain carry a lower risk than those in arteries at the rear of the brain.[3–5] Since its introduction in clinical practice in the 1990s, endovascular coiling for the treatment of cerebral aneurysms

has gained widespread use.[4,6] Noninvasive coil embolization for an unruptured aneurysm is relatively safe compared with invasive surgical treatment such as aneurysmal clipping.[3,4] The structure of the platinum coil adjacent to the intimal surface of the artery facilitates the reconstruction of the parent artery by stimulating endothelial growth that promotes stasis, platelet adhesion, clotting, thrombosis, and occlusion of the aneurysm, resulting in blood flow remodeling.[7] Improvements in techniques and management in recent years have facilitated a reduction in procedural risks associated with coil embolization for unruptured cerebral aneurysms;[6,8] however, acute and delayed thromboembolic events,[9] including stroke and transient ischemic attacks (TIA), remain the most common clinical complications[6,10] with reported incidence rates of 4–28%.

Comments are closed.